Table 2.
PK–PD model parameters.
| LVF (4 µg/mL) | LVF+ Rh2 (1 μM) | LVF+ Rh2 (5 μM) | LVF+ Rh2 (10 μM) | |||||
|---|---|---|---|---|---|---|---|---|
| Mean | CV (%) | Mean | CV (%) | Mean | CV (%) | Mean | CV (%) | |
| k | 0.086 | 36 | 0.077 | 45 | 0.085 | 38 | 0.071 | 41 |
| Fa (×10−3) | 10.5 | 21 | 14.3 | 25 | 17.6* | 31 | 21.4** | 28 |
| EC50 | 10.6 | 32 | 12.4 | 42 | 9.4 | 33 | 11.8 | 37 |
| Emax | 310 | 24 | 301 | 35 | 321 | 31 | 305 | 25 |
The significance is indicated by *P < 0.05, **P < 0.01, versus LVF single treatment group.